Selvita is a drug discovery CRO. The company was established in 2007 and currently employs over 450 scientists, among which 30% are PhDs. Selvita provides comprehensive solutions involving in silico drug design, synthesis of target-focused libraries, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro development.


Andrzej Nieradka Business Development Manager Phone: 650 660 7899
1001 Bayhill Drive, Suite 245 San Bruno, CA 94066